Bioxytran (BIXT) Net Equity Issued and Repurchased (2010 - 2026)
Bioxytran (BIXT) recorded Net Equity Issued and Repurchased of $45,346 in Q2 2026, down 68.9% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
On a TTM basis, Bioxytran's Net Equity Issued and Repurchased came in at $191,047 as of Jun 30, 2026; for FY2025, it was $438,986, up 596.8% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $63,000 in FY2024 (-87.5%), $505,361 in FY2023 (-25.5%), $678,000 in FY2022 (+13.0%) and $600,000 in FY2021 (-36.8%).
- The Q2 2026 figure is the lowest quarterly Net Equity Issued and Repurchased since Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | 45,346.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45,346.00 |
| Mar 31, 2026 | 145,701.00 |
| Jun 30, 2024 | 59,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Sep 30, 2023 | 390,361.00 |
| Jun 30, 2023 | 65,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 78,000.00 |
| Jun 30, 2021 | 150,000.00 |
| Mar 31, 2021 | 450,000.00 |
| Jun 30, 2016 | 25,000.00 |
| Mar 31, 2016 | 25,000.00 |
| Sep 30, 2012 | 5,250.00 |
| Jun 30, 2012 | 2,000.00 |
| Mar 31, 2012 | 10,000.00 |
| Dec 31, 2011 | 145,300.00 |
| Sep 30, 2011 | -26,939.00 |
| Jun 30, 2011 | 291,641.00 |
| Mar 31, 2011 | 138,745.00 |
| Dec 31, 2010 | 32,754.00 |
API Access
Bioxytran Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();